Inflammopharmacology
Springer International Publishing · Netherlands
Metrics
- Impact factor
- 6.3+1 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.373Q1 SCImago
- h-index
- 45
- CAS tier
- Tier 1 Chinese Academy of Sciences
- Citations per paper
- 6.79 last 2 years
- Articles per year
- 105
- Self-citation
- 4.3%
- Fee (APC), est.
- $3,365 estimated, check the journal
About this journal
- ISSN
- 0925-4692 (print) · 1568-5608 (online)
- Publisher
- Springer International Publishing · Springer Nature
- Country
- Netherlands · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 20.4% gold OA
- Founded
- 1991
- Frequency
- 6 issues per year
- Original research
- 68.1%
- Subject areas
- Immunology and Microbiology, Medicine, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Immunologytoxicology, Toxicology
- Common topics
- Medicine, Biology, Internal medicine, Chemistry, Biochemistry
Similar journals
- Q1WoS
Blood
Impact factor 23.9h-index 426SJR 5.91 - Q1WoS
Journal of Experimental Medicine
Impact factor 11.6h-index 411SJR 5.83 - Q1WoS
Nature Biotechnology
Impact factor 44.5h-index 399SJR 23.11 - Q1WoS
Arthritis & Rheumatology
Impact factor 9.9h-index 373SJR 4.06 - Q1WoS
EMBO Journal
Impact factor 8.4h-index 368SJR 4.41 - Q1WoS
Immunity
Impact factor 30.6h-index 355SJR 16.48
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals